insights_auto
Why is MRNA up 14.21%?
Dive Deeperchevron_right
MRNA:NASDAQ
Moderna Inc
$225.00
arrow_upward
+14.21%(+28.00) 1D
$225.06
arrow_upward
+0.03% (+0.059)bedtimeAfter hours
Closed: Oct 9, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MRNA...
Open
$199.00
High
$225.00
Low
$197.17
Mkt. cap
89.83B
Avg. vol.
16.88M
Volume
28.88M
52-wk high
$225.00
52-wk low
$22.29
EPS
-$7.98
Beta
1.09
Shares outstanding
399.24M
No. of employees
5K
Open
$199.00
High
$225.00
Low
$197.17
Mkt. cap
89.83B
Avg. vol.
16.88M
Volume
28.88M
52-wk high
$225.00
52-wk low
$22.29
EPS
-$7.98
Beta
1.09
Shares outstanding
399.24M
No. of employees
5K
News stories
From web sources and news partners
Simply Wall Street
·
1 hour ago
Cancer Vaccine Stocks Gaining Attention After Moderna Shares Jumped On US Backing
Stocks Down Under
·
1 hour ago
Moderna (NASDAQ:MRNA) Stock Surges 14% as Nasdaq-100 Return and Cancer Vaccine Hopes Fuel Rally
Seeking Alpha
·
1 hour ago
Moderna gains 14% to set fresh 52-week high (MRNA:NASDAQ)
Timothy Sykes
·
1 hour ago
MRNA Stock Builds Momentum Ahead Of Nasdaq-100 Debut
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
About Moderna Inc